[Federal Register Volume 78, Number 102 (Tuesday, May 28, 2013)]
[Notices]
[Pages 31939-31940]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-12598]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation of Nominations for Membership on the National 
Vaccine Advisory Committee

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health 
Service (PHS) Act, as amended. The Committee is governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), 
which sets forth standards for the formation and use of advisory 
committees.

SUMMARY: The National Vaccine Program Office (NVPO), a program office 
within the Office of the Assistant Secretary for Health, Department of 
Health and Human Services (HHS), is soliciting nominations of qualified 
candidates to be considered for appointment as members to the National 
Vaccine Advisory Committee (NVAC). The activities of this Committee are 
governed by the Federal Advisory Committee Act (FACA). Management 
support for the activities of this Committee is the responsibility of 
the NVPO.
    Consistent with the National Vaccine Plan, the Committee advises 
and makes recommendations to the Assistant Secretary for Health in his 
capacity as the Director of the National Vaccine Program, on matters 
related to the Program's responsibilities. Specifically, the Committee 
studies and recommends ways to encourage the availability of an 
adequate supply of safe and effective vaccination products in the 
United States; recommends research priorities and other measures to 
enhance the safety and efficacy of vaccines. The Committee also advises 
the Assistant Secretary for Health in the implementation of Sections 
2102 and 2103 of the PHS Act; and identifies annually the most 
important areas of government and non-government cooperation that 
should be considered in implementing Sections 2102 and 2103 of the PHS 
Act.

DATES: All nominations for membership on the Committee must be received 
no later than 5:00 p.m. EDT on June 30, 2013, at the address listed 
below.

ADDRESSES: All nominations should be mailed or delivered to: Bruce 
Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of the 
Assistant Secretary for Health, Department of Health and Human 
Services, 200 Independence Avenue SW., Room 715-H, Hubert H. Humphrey 
Building, Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Mr. Guillermo Avil[eacute]s-Mendoza, 
J.D., LL.M., Public Health Advisor, National Vaccine Program Office, 
Department of Health and Human Services, 200 Independence Avenue SW., 
Room 739G.4, Hubert H. Humphrey Building, Washington, DC 20201; (202) 
205-2982; [email protected].
    A copy of the Committee charter which includes the Committee's 
structure and functions as well as a list of the current membership can 
be obtained by contacting Mr. Avil[eacute]s-Mendoza or by accessing the 
NVAC Web site at: www.hhs.gov/nvpo/nvac.

SUPPLEMENTARY INFORMATION: Committee Function, Qualifications, and 
Information Required: As part of an ongoing effort to enhance 
deliberations and discussions with the public on vaccine and 
immunization policy, nominations are being sought for interested 
individuals to serve on the Committee. Individuals selected for 
appointment to the Committee will serve as voting members. The NVAC 
consists of 17 voting members. The Committee is composed of 15 public 
members, including the Chair, and two representative members. Public 
members shall be selected from individuals who are engaged in vaccine 
research or the manufacture of vaccines, or who are physicians, members 
of parent organizations concerned with immunizations, representatives 
of state or local health agencies or public health organizations. 
Representative members shall be selected from the vaccine manufacturing 
industry who are engaged in vaccine research or the manufacture of 
vaccines. Individuals selected for appointment to the Committee can be 
invited to serve terms of up to four years.
    All NVAC members are authorized to receive the prescribed per diem

[[Page 31940]]

allowance and reimbursement for travel expenses that are incurred to 
attend meetings and conduct authorized Committee-related business, in 
accordance with Standard Government Travel Regulations. Individuals who 
are appointed to serve as public members are authorized also to receive 
honorarium for attending Committee meetings and to carry out other 
authorized Committee-related business. Individuals who are appointed to 
serve as representative members for a particular interest group or 
industry are not authorized to receive honorarium for the performance 
of these duties.
    This announcement is to solicit nominations of qualified candidates 
to fill positions on the NVAC that are scheduled to be vacated in the 
public member category. The positions are scheduled to be vacated 
during the calendar year 2013.

Nominations

    In accordance with the charter, persons nominated for appointment 
as members of the NVAC should be among authorities knowledgeable in 
areas related to vaccine safety, vaccine effectiveness, and vaccine 
supply. Nominations should be typewritten. The following information 
should be included in the package of material submitted for each 
individual being nominated for consideration: (1) A letter of 
nomination that clearly states the name and affiliation of the nominee, 
the basis for the nomination (i.e., specific attributes which qualify 
the nominee for service in this capacity); and a statement that the 
nominee is willing to serve as a member of the Committee (2) the 
nominator's name, address and daytime telephone number, home and/or 
work address, telephone number, and email address; and (3) a current 
copy of the nominee's curriculum vitae.
    Individuals can nominate themselves for consideration of 
appointment to the Committee. All nominations must include the required 
information. Incomplete nominations will not be processed for 
consideration. The letter from the nominator and certification of the 
nominated individual must bear original signatures; reproduced copies 
of these signatures are not acceptable. Applications cannot be 
submitted by facsimile. The names of Federal employees should not be 
nominated for consideration of appointment to this Committee. The 
Department makes every effort to ensure that the membership of HHS 
Federal advisory committees is fairly balanced in terms of points of 
view represented and the committee's function. Every effort is made to 
ensure that a broad representation of geographic areas, gender, ethnic 
and minority groups, and the disabled are given consideration for 
membership on HHS Federal advisory committees. Appointment to this 
committee shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, disability, and cultural, 
religious, or socioeconomic status.
    The Standards of Ethical Conduct for Employees of the Executive 
Branch are applicable to individuals who are appointed as public 
members of Federal advisory committees. Individuals appointed to serve 
as public members of Federal advisory committees are classified as 
special Government employees (SGEs). SGEs are Government employees for 
purposes of the conflict of interest laws. Therefore, individuals 
appointed to serve as public members of NVAC are subject to an ethics 
review. The ethics review is conducted to determine if the individual 
has any interests and/or activities in the private sector that may 
conflict with performance of their official duties as a member of the 
Committee. Individuals appointed to serve as public members of the 
Committee will be required to disclose information regarding financial 
holdings, consultancies, and research grants and/or contracts.

    Dated: May 21, 2013.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy 
Assistant Secretary for Health, Director, National Vaccine Program 
Office.
[FR Doc. 2013-12598 Filed 5-24-13; 8:45 am]
BILLING CODE 4150-28-P